3 results match your criteria: "Keiaikai Chibana Clinic[Affiliation]"

Introduction: The current guidelines for managing hypertension recommend strict blood pressure (BP) control to prevent bleeding complications in patients with hypertension on antithrombotic therapy. However, the target BP value of <130/80 mmHg is achieved in a small proportion of these patients. This study aimed to examine the factors associated with nonachievement of target BP value (≥130/80 mmHg) in patients on antithrombotic therapy.

View Article and Find Full Text PDF

Although numerous studies have demonstrated a strong association between blood pressure (BP) and hemorrhagic complications of antithrombotic therapy, there is still a paucity of information regarding the status of BP control in hypertensive patients on antithrombotic therapy. This cross-sectional, retrospective study was conducted at an outpatient clinic to examine BP control and its associated factors in hypertensive patients receiving or not receiving antithrombotic therapy. Of 26,803 outpatients who had scheduled visits in 2018, 7,800 hypertensive patients met the inclusion criteria, of whom 1,727 cases were on oral antithrombotic drugs.

View Article and Find Full Text PDF

Differences in 24-h blood pressure profile of Japanese hypertensive patients under ARB treatment.

Clin Exp Hypertens

August 2016

a Division of Circulatory and Body Fluid Regulation, Department of Internal Medicine, Faculty of Medicine , University of Miyazaki, Miyazaki , Japan .

Article Synopsis
  • * A study of 211 Japanese hypertensive patients found that while daytime and overall blood pressure readings were similar across five different ARB medications, nighttime blood pressure was significantly lower for those on olmesartan.
  • * Candesartan and telmisartan showed strong correlations between office and 24-hour blood pressure measurements, and differences in ARB treatments had notable effects on blood pressure profiles throughout the day.
View Article and Find Full Text PDF